13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0000909661
Total reported value
$21.7B
$21.7B
150 檔
28.9%
As reported in its official Q4 2025 Form 13F filing, Farallon Capital Management, L.l.c.'s tracked investment portfolio stood at $21.7B with 150 total positions.
Farallon Capital Management, L.l.c. executed strategic sector rebalancing during Q4 2025, establishing 27 new positions while fully exiting 21 holdings and trimming 37 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 9.65% | +20.67% | NEW | |
| 2 | RVMD | Revolution Medicines Inc | Stock-Healthcare | 5.48% | +4.17% | — | |
| 3 | MSFT | Microsoft CORP | Stock-Tech | 5.05% | -3.03% | — | |
| 4 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 4.90% | -2.11% | — | |
| 5 | AON | Aon plc | Stock-Financials | 4.44% | -2.50% | — | |
| 6 | NTRA | Natera Inc | Stock-Healthcare | 4.23% | -0.88% | — | |
| 7 | BSX | Boston Scientific CORP | Stock-Healthcare | 3.35% | -0.60% | — | |
| 8 | RSP | Invesco S&p 500 Equal Weight | ETF-Large Cap & Growth | 3.25% | — | — | |
| 9 | EXEL | Exelixis Inc | Stock-Healthcare | 3.25% | +0.17% | — | |
| 10 | BBIO | Bridgebio Pharma Inc | Stock-Healthcare | 3.25% | -0.27% | — | |
| 11 | HYG | Ishr Ibx Usd Hiyld Cb Etf-ui | ETF-High Yield | 3.04% | — | — | |
| 12 | PTGX | Protagonist Therapeutics Inc | Stock-Other | 2.53% | -0.22% | — | |
| 13 | WAB | Wabtec CORP | Stock-Industrials | 2.49% | -1.18% | — | |
| 14 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 2.49% | -0.37% | — | |
| 15 | ✓ | Cyberark Software LTD. Cmn | Stock-Other | 2.22% | — | — | |
| 16 | DIS | Walt Disney Co/the | Stock-Comm Services | 2.22% | -1.32% | EXIT | |
| 17 | SNPS | Synopsys Inc | Stock-Tech | 2.21% | -1.03% | — | |
| 18 | LLY | Eli Lilly & Co | Stock-Healthcare | 1.90% | — | — | |
| 19 | TMO | Thermo Fisher Scientific Inc | Stock-Healthcare | 1.74% | -0.04% | — | |
| 20 | LNTH | Lantheus Holdings Inc | Stock-Healthcare | 1.70% | +0.45% | — | |
| 21 | ARMK | Aramark | Stock-Industrials | 1.63% | -0.47% | — | |
| 22 | CRM | Salesforce Inc | Stock-Tech | 1.58% | — | — | |
| 23 | SCHW | Schwab (charles) CORP | Stock-Financials | 1.57% | -2.12% | EXIT | |
| 24 | CRNX | Crinetics Pharmaceuticals In | Stock-Other | 1.52% | -0.18% | — | |
| 25 | AVGO | Broadcom Inc | Stock-Tech | 1.46% | -1.13% | — | |
| 26 | LQDA | Liquidia CORP | Stock-Other | 1.41% | +1.22% | — | |
| 27 | NDAQ | Nasdaq Inc | Stock-Financials | 1.37% | — | — | |
| 28 | BEAM | Beam Therapeutics Inc | Stock-Other | 1.32% | +0.24% | — | |
| 29 | KKR | Kkr & Co Inc | Stock-Financials | 1.21% | -0.72% | — | |
| 30 | GOOG | Alphabet Inc-cl C | Stock-Comm Services | 1.17% | -1.63% | EXIT | |
| 31 | MCK | Mckesson CORP | Stock-Healthcare | 1.16% | -1.16% | EXIT | |
| 32 | V | Visa Inc-class A Shares | Stock-Financials | 1.15% | -1.45% | EXIT | |
| 33 | NYT | New York Times Co-a | Stock-Comm Services | 1.07% | — | — | |
| 34 | DAY | Dayforce Inc | Stock-Other | 0.95% | — | — | |
| 35 | GRAL | Grail Inc | Stock-Healthcare | 0.95% | +0.35% | — | |
| 36 | BITW | Bitwise 10 Crypto Index ETF | ETF-Crypto | 0.94% | -0.15% | EXIT | |
| 37 | CBRE | Cbre Group Inc - A | Stock-Real Estate | 0.75% | — | — | |
| 38 | AGIO | Agios Pharmaceuticals Inc | Stock-Other | 0.66% | -0.09% | — | |
| 39 | 260 | Centessa Pharmaceuticals-adr | Stock-Other | 0.63% | -1.09% | EXIT | |
| 40 | BBNX | Beta Bionics Inc | Stock-Other | 0.62% | -0.17% | — | |
| 41 | CAH | Cardinal Health Inc | Stock-Healthcare | 0.56% | -0.44% | EXIT | |
| 42 | TNGX | Tango Therapeutics Inc | Stock-Other | 0.55% | +0.69% | — | |
| 43 | HIMS | Hims & Hers Health Inc | Stock-Healthcare | 0.52% | — | EXIT | |
| 44 | IBIT | Ishares Bitcoin Trust ETF | ETF-Crypto | 0.50% | — | — | |
| 45 | MA | Mastercard Inc - A | Stock-Financials | 0.47% | -1.24% | EXIT | |
| 46 | CDTX | Cidara Therapeutics Inc | Stock-Other | 0.40% | — | — | |
| 47 | THC | Tenet Healthcare CORP | Stock-Healthcare | 0.35% | -0.49% | EXIT | |
| 48 | WELL | Welltower Inc | Stock-Real Estate | 0.30% | -0.23% | — | |
| 49 | TRU | Transunion | Stock-Financials | 0.27% | — | — | |
| 50 | TYRA | Tyra Biosciences Inc | Stock-Other | 0.26% | -0.78% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | RVMD | Revolution Medicines Inc | +2.7% | — | Trim |
| 2 | ✓ | Cyberark Software LTD. Cmn | +2.2% | NEW | New buy |
| 3 | SNPS | Synopsys Inc | +2.2% | NEW | New buy |
| 4 | AMZN | Amazon.com Inc | +1.8% | — | Add |
| 5 | BBIO | Bridgebio Pharma Inc | +1.5% | — | Add |
| 6 | AVGO | Broadcom Inc | +1.5% | NEW | New buy |
| 7 | BSX | Boston Scientific CORP | +1.5% | — | Add |
| 8 | NTRA | Natera Inc | +1.4% | — | Trim |
| 9 | KKR | Kkr & Co Inc | +1.2% | NEW | New buy |
| 10 | AON | Aon plc | +1.1% | — | Add |
| 11 | MSFT | Microsoft CORP | +1% | — | Add |
| 12 | LNTH | Lantheus Holdings Inc | +1% | — | Add |
| 13 | DAY | Dayforce Inc | +1% | NEW | New buy |
| 14 | BITW | Bitwise 10 Crypto Index ETF | +0.9% | NEW | New buy |
| 15 | PTGX | Protagonist Therapeutics Inc | +0.9% | — | Trim |
| 16 | LLY | Eli Lilly & Co | +0.7% | — | Unchanged |
| 17 | WAB | Wabtec CORP | +0.7% | — | Add |
| 18 | GRAL | Grail Inc | +0.6% | — | Add |
| 19 | LQDA | Liquidia CORP | +0.6% | — | Add |
| 20 | CRNX | Crinetics Pharmaceuticals In | +0.5% | — | Add |
| 21 | CAH | Cardinal Health Inc | +0.4% | — | Add |
| 22 | SPY | Ss Spdr S&p 500 ETF Trust-us | +0.4% | — | Trim |
| 23 | BEAM | Beam Therapeutics Inc | +0.3% | — | Unchanged |
| 24 | V | Visa Inc-class A Shares | +0.3% | — | Add |
| 25 | WELL | Welltower Inc | +0.3% | NEW | New buy |
| 26 | SCHW | Schwab (charles) CORP | +0.3% | — | Add |
| 27 | BBNX | Beta Bionics Inc | +0.3% | — | Unchanged |
| 28 | ARMK | Aramark | +0.2% | — | Add |
| 29 | INSM | Insmed Inc | +0.2% | — | Add |
| 30 | CDTX | Cidara Therapeutics Inc | +0.2% | — | Trim |
| 31 | 260 | Centessa Pharmaceuticals-adr | +0.2% | — | Add |
| 32 | TYRA | Tyra Biosciences Inc | +0.2% | — | Add |
| 33 | TNGX | Tango Therapeutics Inc | +0.2% | — | Add |
| 34 | GPCR | Structure Therapeutics Inc | +0.2% | NEW | New buy |
| 35 | SUNC | Sunococorp LLC | +0.1% | NEW | New buy |
| 36 | ✓ | +0.1% | NEW | New buy | |
| 37 | MCK | Mckesson CORP | +0.1% | — | Trim |
| 38 | 430 | Terns Pharmaceuticals Inc | +0.1% | NEW | New buy |
| 39 | ENTA | Enanta Pharmaceuticals Inc | +0.1% | — | Add |
| 40 | AMKR | Amkor Technology Inc | +0.1% | NEW | New buy |
| 41 | BIDU | Baidu Inc - Spon Adr | +0.1% | — | Add |
| 42 | VSTM | Verastem Inc | +0.1% | NEW | New buy |
| 43 | ASMB | Assembly Biosciences Inc | +0.1% | — | Unchanged |
| 44 | NDAQ | Nasdaq Inc | +0.1% | — | Trim |
| 45 | GOOG | Alphabet Inc-cl C | +0.1% | — | Trim |
| 46 | MDLN | Medline Inc-cl A | +0.1% | NEW | New buy |
| 47 | GH | Guardant Health Inc | +0.1% | — | Add |
| 48 | NERV | Minerva Neurosciences Inc | 0% | NEW | New buy |
| 49 | WGS | Genedx Holdings CORP | 0% | — | Add |
| 50 | ETH | Grayscale Ethereum Staking M | 0% | NEW | New buy |
According to official SEC Form 13F filings, Farallon Capital Management, L.l.c. reported a total U.S. public equity portfolio value of $21.7B across 150 disclosed positions in Q4 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including SPY, RVMD, MSFT) accounted for 28.9% of total reported equity market value during Q4 2025.
Top New Position Initiated
CYBERARK SOFTWARE LTD. CMN
市值: $469.7M
Top Position Liquidated / Trimmed
ADSK
前期市值: $528.2M
During Q4 2025, Farallon Capital Management, L.l.c.'s top holdings by market value included SPY (9.7%)、RVMD (5.5%)、MSFT (5.0%). The largest single position, SPY, represented 9.7% of total portfolio value.
In Q4 2025, Farallon Capital Management, L.l.c. made 108 total portfolio adjustments, initiating 27 new buys, adding to 23 positions, trimming 37 holdings, and fully liquidating 21 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.